General Information of Drug Off-Target (DOT) (ID: OTSJISGF)

DOT Name CKLF-like MARVEL transmembrane domain-containing protein 2 (CMTM2)
Synonyms Chemokine-like factor superfamily member 2
Gene Name CMTM2
Related Disease
Colorectal carcinoma ( )
Glioblastoma multiforme ( )
Juvenile idiopathic arthritis ( )
Sezary syndrome ( )
Neoplasm ( )
UniProt ID
CKLF2_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MAPKAAKGAKPEPAPAPPPPGAKPEEDKKDGKEPSDKPQKAVQDHKEPSDKPQKAVQPKH
EVGTRRGCRRYRWELKDSNKEFWLLGHAEIKIRSLGCLIAAMILLSSLTVHPILRLIITM
EISFFSFFILLYSFAIHRYIPFILWPISDLFNDLIACAFLVGAVVFAVRSRRSMNLHYLL
AVILIGAAGVFAFIDVCLQRNHFRGKKAKKHMLVPPPGKEKGPQQGKGPEPAKPPEPGKP
PGPAKGKK
Tissue Specificity Highly expressed in testis.

Molecular Interaction Atlas (MIA) of This DOT

5 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Colorectal carcinoma DIS5PYL0 Definitive Biomarker [1]
Glioblastoma multiforme DISK8246 Strong Altered Expression [2]
Juvenile idiopathic arthritis DISQZGBV Strong Biomarker [3]
Sezary syndrome DISFMTC7 Strong Biomarker [4]
Neoplasm DISZKGEW moderate Biomarker [5]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
1 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of CKLF-like MARVEL transmembrane domain-containing protein 2 (CMTM2). [6]
------------------------------------------------------------------------------------
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of CKLF-like MARVEL transmembrane domain-containing protein 2 (CMTM2). [7]
------------------------------------------------------------------------------------

References

1 Genome-wide analysis of aberrant DNA methylation for identification of potential biomarkers in colorectal cancer patients.Asian Pac J Cancer Prev. 2012;13(5):1917-21. doi: 10.7314/apjcp.2012.13.5.1917.
2 Systematic investigation of CMTM family genes suggests relevance to glioblastoma pathogenesis and CMTM1 and CMTM3 as priority targets.Genes Chromosomes Cancer. 2015 Jul;54(7):433-43. doi: 10.1002/gcc.22255. Epub 2015 Apr 30.
3 Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.Arthritis Rheum. 2009 Jul;60(7):2113-23. doi: 10.1002/art.24534.
4 Epigenomic Analysis of Szary Syndrome Defines Patterns of Aberrant DNA Methylation and Identifies DiagnosticMarkers.J Invest Dermatol. 2016 Sep;136(9):1876-1884. doi: 10.1016/j.jid.2016.03.042. Epub 2016 Apr 23.
5 Chemokine and Chemokine Receptor Profiles in Metastatic Salivary Adenoid Cystic Carcinoma.Anticancer Res. 2016 Aug;36(8):4013-8.
6 Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):270-80.
7 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.